Preoperative platelet count and survival prognosis in resected pancreatic ductal adenocarcinoma

World Journal of Surgery

Volumn 32, Issue 6, 2008, Pages 1051-1056

  Domínguez, Ismael ^a   Crippa, Stefano ^a   Thayer, Sarah P ^a   Hung, Yin P ^a   Ferrone, Cristina R ^a   Warshaw, Andrew L ^a   Fernández Del Castillo, Carlos ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PREOPERATIVE EVALUATION; PROGNOSIS; THROMBOCYTE COUNT;

AGED; CARCINOMA, PANCREATIC DUCTAL; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC NEOPLASMS; PLATELET COUNT; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 43949133845     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9423-6     Document Type: Article

References (32)

1. Jemal A, Murray T, Ward E, et al. (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10-30
2. Tsiotos GG, Farnell MB, Sarr MG (1999) Are the results of pancreatectomy for pancreatic cancer improving? World J Surg 23:913-919
3. Eloubeidi MA, Desmond RA, Wilcox CM, et al. (2006) Prognostic factors for survival in pancreatic cancer: a population-based study. Am J Surg 192:322-329
4. Sohn TA, Yeo CJ, Cameron JL, et al. (2000) Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4:567-579
5. Lim JE, Chien MW, Earle CC (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based practices and effectiveness. J Clin Oncol 103:349-357
6. Schafer AI (2004) Thrombocytosis. N Engl J Med 350:1211-1219
7. Sierki E, Wojtukiewicz MZ (2004) Platelets and angiogenesis in malignancy. Semin Thromb Hemost 30:95-108
8. Bensalah K, Leray E, Fergelot P, et al. (2006) Prognostic value of thrombocytosis in renal cell carcinoma. J Urol 175:859-863
9. Gogus C, Baltaci S, Filiz E, et al. (2004) Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma. Urology 63:447-450
10. Symbas NP, Townsend MF, El-Galley R, et al. (2000) Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU 86:203-207
11. Suppiah R, Shaheen PE, Elson P, et al. (2006) Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma. Cancer 107:1793-1800
12. Inoue K, Kohashikawa K, Suzuki S, et al. (2004) Prognostic significance of thrombocytosis in renal cell carcinoma patients. Int J Urol 11:364-367
13. O'Keefe SC, Marshall FF, Issa MM, et al. (2002) Thrombocytosis is associated with a significant increase in the cancer specific death after radical nephrectomy. J Urol 168:1378-1380
14. Hernandez E, Donohue KA, Anderson LL, et al. (2000) The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a gynecologic oncology group study. Gynecol Oncol 78:237-242
15. Hernandez E, Lavine M, Dunton CJ, et al. (1992) Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer 69:2975-2977
16. Taucher S, Salat A, Gnant M, et al. (2003) Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemost 89:1098-1106
17. Li A, Madden AC, Cass I, et al. (2004) The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol 92:211-214
18. Nather A, Mayerhofer K, Grimm C, et al. (2003) Thrombocytosis and anemia in women with recurrent ovarian cancer prior to a second-line chemotherapy. Anticancer Res 23:2991-2994
19. Tamussino KF, Gucer F, Reich O, et al. (2001) Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer 11:236-240
20. Scholz HS, Petru E, Gucer F, et al. (2000) Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res 20:3983-3985
21. Hefler L, Mayerhofer K, Leibman B, et al. (2000) Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumour Biol 21:309-314
22. Pedersen LM, Milman N (1996) Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 9:1826-1830
23. Aoe K, Hiraki A, Ueoka H, et al. (2004) Thrombocytosis as a useful prognostic indicator in patients with lung cancer. Respiration 71:170-173
24. Brown KM, Domin C, Aranha GV, et al. (2001) Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas. Am J Surg 189:278-282
25. Suzuki K, Aiura K, Kitagou M, et al. (2004) Platelet counts closely correlate with the disease-free survival interval of pancreatic cancer patients. Hepatogastroenterology 51:847-853
26. Schwartz RE, Kenry H (2001) Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma. Hepatogastroenterology 48:1493-1498
27. Aydogan T, Kanbay M, Alici O, et al. (2006) Incidence and etiology of thrombocytosis in an adult Turkish population. Platelets 17:328-331
28. Gudjonsson B (2002) Survival statistics gone awry. Pancreatic cancer, a case in point. J Clin Gastroenterol 35:180-184
29. Griesshammer M, Bangerter M, Sauer T, et al. (1999) Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J Int Med 245:295-300
30. Ikeda M. Furukawa H, Imamura H, et al. (2002) Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9:287-291
31. Kuhlmann KFD, de Castro SMM, Wesseling JG, et al. (2004) Surgical treatment of pancreatic adenocarcinoma: actual survival and prognostic factors in 343 patients. Eur J Cancer 40:549-558
32. Ferrone CR, Finkelstein DM, Thayer SP, et al. (2006) Perioperative CA 19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol 24:2897-2902